meglumine has been researched along with Cancer of Ovary in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (18.18) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 8 (72.73) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jung, DC; Oh, YT; Park, SY | 1 |
| Bats, AS; Boussouar, S; Chamming's, F; Fournier, LS; Kao, E; Le-Frere-Belda, MA | 1 |
| Dilks, P; Narayanan, P; Reznek, R; Rockall, A; Sahdev, A | 1 |
| Choi, D; Im, GH; Kim, JH; Lee, JH; Lee, WJ; Yang, J | 1 |
| Bernardin, L; Dilks, P; Liyanage, S; Miquel, ME; Rockall, A; Sahdev, A | 1 |
| Aubert, E; Balvay, D; Bazot, M; Cuenod, CA; Daraï, E; Rouzier, R; Thomassin-Naggara, I | 1 |
| Cherenkov, VG; Petrov, AB; Shpenkova, AA; Vasil'eva, TM | 1 |
| Liyanage, S; Narayanan, P; Rockall, A; Sahdev, A; Singh, N; Sohaib, A; Tang, YZ | 1 |
| Bazot, M; Callard, P; Cuenod, CA; Daraï, E; Thomassin, J; Thomassin-Naggara, I | 1 |
| Carter, WD; Low, RN; Saleh, F; Sigeti, JS | 1 |
| Hricak, H; Stern, JL; Stevens, SK | 1 |
1 trial(s) available for meglumine and Cancer of Ovary
| Article | Year |
|---|---|
[Use of Reamberin for the prevention of adverse effects of combined antineoplastic agents in stage III-IV ovarian cancer during induction treatment].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cystadenocarcinoma, Serous; Female; Humans; Meglumine; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Primary Prevention; Protective Agents; Remission Induction; Succinates | 2012 |
10 other study(ies) available for meglumine and Cancer of Ovary
| Article | Year |
|---|---|
Differentiation between borderline and benign ovarian tumors: combined analysis of MRI with tumor markers for large cystic masses (≥5 cm).
Topics: Adult; Biomarkers, Tumor; CA-125 Antigen; CA-19-9 Antigen; Contrast Media; Diagnosis, Differential; Female; Humans; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Ovarian Neoplasms; Predictive Value of Tests; Retrospective Studies; Sensitivity and Specificity | 2016 |
Ruptured benign serous ovarian cystadenoma mimicking ovarian malignancy with peritoneal carcinomatosis.
Topics: Carcinoembryonic Antigen; Contrast Media; Cystadenoma, Papillary; Cystadenoma, Serous; Diagnosis, Differential; Female; Humans; Image Enhancement; Magnetic Resonance Imaging; Meglumine; Middle Aged; Organometallic Compounds; Ovarian Neoplasms; Peritoneal Neoplasms; Rupture, Spontaneous | 2016 |
Can quantitative dynamic contrast-enhanced MRI independently characterize an ovarian mass?
Topics: Adolescent; Adult; Contrast Media; Female; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Meglumine; Middle Aged; Organometallic Compounds; Ovarian Neoplasms; Reproducibility of Results; Sensitivity and Specificity; Young Adult | 2010 |
Quantitative dynamic contrast-enhanced MRI for mouse models using automatic detection of the arterial input function.
Topics: Animals; Computer Simulation; Contrast Media; Female; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Meglumine; Mice; Mice, Inbred BALB C; Models, Biological; Organometallic Compounds; Ovarian Neoplasms; Reproducibility of Results; Sensitivity and Specificity | 2012 |
Effectiveness of semi-quantitative multiphase dynamic contrast-enhanced MRI as a predictor of malignancy in complex adnexal masses: radiological and pathological correlation.
Topics: Adnexal Diseases; Contrast Media; Diagnosis, Differential; Female; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Ovarian Neoplasms; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic | 2012 |
Quantitative dynamic contrast-enhanced MR imaging analysis of complex adnexal masses: a preliminary study.
Topics: Adnexal Diseases; Adult; Aged; Aged, 80 and over; Algorithms; Contrast Media; Diagnosis, Differential; Female; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Meglumine; Metabolic Clearance Rate; Middle Aged; Organometallic Compounds; Ovarian Neoplasms; Pilot Projects; Reproducibility of Results; Sensitivity and Specificity | 2012 |
The MRI features of histologically proven ovarian cystadenofibromas-an assessment of the morphological and enhancement patterns.
Topics: Adult; Aged; Contrast Media; Cystadenofibroma; Female; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Meglumine; Middle Aged; Organometallic Compounds; Ovarian Neoplasms; Retrospective Studies | 2013 |
Epithelial ovarian tumors: value of dynamic contrast-enhanced MR imaging and correlation with tumor angiogenesis.
Topics: Adolescent; Adult; Aged; Contrast Media; Female; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Neoplasms, Glandular and Epithelial; Neovascularization, Pathologic; Organometallic Compounds; Ovarian Neoplasms; Reproducibility of Results; Sensitivity and Specificity | 2008 |
Ovarian cancer: comparison of findings with perfluorocarbon-enhanced MR imaging, In-111-CYT-103 immunoscintigraphy, and CT.
Topics: Abdominal Neoplasms; Antibodies, Monoclonal; Contrast Media; Drug Combinations; Female; Fluorocarbons; Gadolinium DTPA; Humans; Hydrocarbons, Brominated; Indium Radioisotopes; Magnetic Resonance Imaging; Meglumine; Middle Aged; Oligopeptides; Organometallic Compounds; Ovarian Neoplasms; Pelvic Neoplasms; Pentetic Acid; Peritoneal Neoplasms; Predictive Value of Tests; Prospective Studies; Radioimmunodetection; Sensitivity and Specificity; Tomography, X-Ray Computed | 1995 |
Ovarian lesions: detection and characterization with gadolinium-enhanced MR imaging at 1.5 T.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Meglumine; Middle Aged; Neoplasm Staging; Organometallic Compounds; Ovarian Diseases; Ovarian Neoplasms; Ovary; Pentetic Acid | 1991 |